Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
6.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.9K
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phyto-Nanotherapeutics for Alzheimer's Disease: Current Progress and Future Perspectives.

Central nervous system agents in medicinal chemistry·2026
Same author

Integrated multiclass driver ctDNA profiling enables MPNST detection and monitoring in NF1 patients.

NPJ precision oncology·2026
Same author

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

British journal of cancer·2026
Same author

Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma.

JCO precision oncology·2026
Same author

An insight into the molecular identity and distribution of <i>Microhyla taraiensis</i> (Anura, Microhylidae) in Khyber Pakhtunkhwa, Pakistan.

ZooKeys·2026
Same author

Enhancing Compliance: Tailored Training on IATA Regulations for Shipping Infectious Substances and Biological Specimens for Targeted Cohorts in Pakistan.

Applied biosafety : journal of the American Biological Safety Association·2026
Same journal

Transcription Factor and Tumorigenesis: Perspectives and Concluding Remarks.

Critical reviews in oncogenesis·2026
Same journal

Review Article: Intratumoral Immunotherapy: Old Discoveries and Recent Developments in Sarcomas.

Critical reviews in oncogenesis·2026
Same journal

Review Article: Dynamin-Related Protein 1 in Cancer Progression: Mechanisms and Implications.

Critical reviews in oncogenesis·2026
Same journal

Review Article: EZH2 in Pancreatic Cancer: Epigenetic Driver and Therapeutic Target.

Critical reviews in oncogenesis·2026
Same journal

Review Article: YY2 in Tumor Regulation: Core Mechanisms and Functional Networks.

Critical reviews in oncogenesis·2026
Same journal

Review Article: Decoding the Role of PBX3 in Cancer: Molecular Mechanisms and Therapeutic Strategies.

Critical reviews in oncogenesis·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K

Pediatric Rhabdomyosarcoma.

Jack F Shern1, Marielle E Yohe1, Javed Khan1

  • 1Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland; Pediatric Oncology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.

Critical Reviews in Oncogenesis
|September 10, 2015
PubMed
Summary
This summary is machine-generated.

Rhabdomyosarcoma, a common childhood cancer, still has poor outcomes for some patients. New genomic studies reveal targets for developing specialized therapies.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.8K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

3.0K

Related Experiment Videos

Last Updated: Apr 4, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.8K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

3.0K

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Genomics

Background:

  • Rhabdomyosarcoma is the most frequent soft-tissue sarcoma in children.
  • Despite advances, certain patient groups experience significant morbidity and mortality.
  • Understanding the molecular landscape is crucial for improving outcomes.

Purpose of the Study:

  • To identify novel molecular targets for rhabdomyosarcoma treatment.
  • To leverage recent genomic findings for therapeutic development.

Main Methods:

  • Utilizing sophisticated genomics techniques.
  • Employing next-generation sequencing (NGS) experiments.

Main Results:

  • Genetic and molecular characterization of rhabdomyosarcoma tumors.
  • Identification of exploitable molecular pathways.

Conclusions:

  • Genomic insights offer promising avenues for targeted therapies.
  • New treatment strategies are needed for high-risk rhabdomyosarcoma patients.